Steward Partners Investment Advisory, LLC Tandem Diabetes Care Inc Transaction History

Steward Partners Investment Advisory, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$19.33 - $36.22 $1,353 - $2,535	70 New	70 $1,000
Q3 2022 Nov 10, 2022	SELL	$43.76 - $68.97 $9,627 - $15,173	-220 Reduced 68.97%	99 $5,000
Q2 2022 Aug 04, 2022	SELL	$53.22 - $123.09 $53 - $123	-1 Reduced 0.31%	319 $19,000
Q3 2021 Nov 12, 2021	SELL	$93.51 - $129.4 $9,351 - $12,940	-100 Reduced 23.81%	320 $38,000
Q2 2021 Aug 13, 2021	SELL	$77.0 - $100.19 $23,100 - $30,057	-300 Reduced 41.67%	420 $41,000
Q1 2021 May 14, 2021	BUY	$81.28 - $104.34 $40,640 - $52,170	500 Added 227.27%	720 $63,000
Q4 2019 Jan 17, 2020	BUY	$53.13 - $71.19 $11,688 - $15,661	220 New	220 $13,000

359

72.2M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.37B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.